Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
4.100
+0.180 (4.59%)
At close: Nov 22, 2024, 4:00 PM
4.400
+0.300 (7.32%)
After-hours: Nov 22, 2024, 5:37 PM EST
Exagen Employees
As of December 31, 2023, Exagen had 179 total employees, including 174 full-time and 5 part-time employees. The number of employees decreased by 25 or -12.25% compared to the previous year.
Employees
179
Change (1Y)
-25
Growth (1Y)
-12.25%
Revenue / Employee
$311,458
Profits / Employee
-$94,564
Market Cap
72.31M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Rockwell Medical | 237 |
Allakos | 131 |
Hyperfine | 131 |
VolitionRx | 110 |
ALX Oncology Holdings | 72 |
electroCore | 68 |
BioAtla | 65 |
Vivani Medical | 44 |
XGN News
- 8 days ago - Exagen Inc. Completes Validation and Regulatory Submission for New Lupus and Rheumatoid Arthritis Biomarkers on the AVISE® CTD Platform - GlobeNewsWire
- 10 days ago - Exagen, Inc. (XGN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Exagen Announces Acceptance of Five Abstracts at 2024 American College of Rheumatology Convergence - GlobeNewsWire
- 2 months ago - Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference - GlobeNewsWire
- 3 months ago - Exagen, Inc. (XGN) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - Exagen Inc. to Participate in the Canaccord Genuity 44th Annual Growth Conference - GlobeNewsWire
- 4 months ago - Exagen Appoints Jeffrey G. Black as New Chief Financial Officer - GlobeNewsWire
- 4 months ago - Exagen to Announce Second Quarter 2024 Results on August 5, 2024 - GlobeNewsWire